Regencell Bioscience Soars Over 31% on Accelerated Commercialization Prospects of Brain-Computer Interface Technologies

Regencell Bioscience Holdings Soars Over 31% in U.S. Stocks. On the news front, Elon Musk recently stated on social media that his brain-computer interface company, Neuralink, will begin "mass production" of brain-computer interface devices in 2026. This will be accompanied by a highly streamlined and almost fully automated surgical procedure. The key breakthrough is that the electrode threads in the device will pass directly through the dura mater without the need for its removal.

Changjiang SecuritiesThe research report pointed out that currently, China's brain-computer interface industry is yielding frequent results. With policy support, the brain-computer interface industry is expected to usher in a period of development opportunities, accelerating the transformation from industrial research to commercialization, thereby speeding up the large-scale commercial implementation of brain-computer interfaces.

According to the Caixin Subject Database, among related listed companies:

SunnyouForward-looking Layout of Brain-Computer Interface and RehabilitationRobot...and other cutting-edge technologies. Brain-computer interface is a key strategic R&D direction for the company in recent years. Currently, a significant portion of the company's rehabilitation equipment incorporates brain-computer interface technology.

MedlanderExpected to obtain the first brain-computer interface medical device registration certificate (Brain-Computer Interface Transcranial Magnetic Stimulator) in the first quarter of 2026.